My cost basis is $29...so I'll take the 35% profit on that PT. Having said this, it will prolly be double that in a year. All these Pharm stocks are marching to the same tune right now...AGN...VRX..have same chart pattern and ENDP is going out with the tide with all the rest.
CEO already cut them 6 weeks ago at conference. I believe we are actually in Q3 now which is when most of the revenue comes in. I expect 2Q to be mediocre but along conference guidelines, and then some news that 2H is still looking strong.
And those of you who are part of this stock manipulation scheme should be thrown in jail. A pharma stock trading at now less than 5 times forward earnings is a joke. This stock should be at least $65 - $70 per share and will be in due time.
I would argue that more than "some of this" has been priced in. Guidance could be cut in half and this company is still valued lower than the broader market. Nevermind the fact that ENDP is growing top line, and the broader market isn't.
Not saying we're headed back to $90 immediately, either. But I believe there is money to be made as confidence slowly returns.
There is one moron on market pulse who says he's going to buy at 13 ... so 2x earnings? With institutions owning almost all the float, market pulse is yet another false marketing tool for morons to post ridiculous thoughts and comments. If you start reading their predictions, your definitely not going to beat the markets. For every correct prediction, they have more than one wrong prediction. Flip a coin.
That should be the headline. Corrupt Wall street hedge funds at it again with another group of analysts whose pockets are lined to follow the easy money. Disgusting. What will happen next is they will buy in in the 26 - 28 range, then there will be an earnings surprise and stock will jump to 35+ again. The banks should not be allowed to have analysts put public price targets on stocks. That is how they manipulate the markets. This rule should be passed by Congress. Only analysts not affiliated with banks, like true research firms, should be able to disclose price targets to the public.
Sentiment: Strong Buy
I don't think the news will be good. Smart money has been bailing on this stock the past couple months as reflected in the stock price. Opiod related sales have been very weak across the board. Pharma pricing issues are a concern now and in the future. The only good thing is the expectations are low and the stock has priced some of this in already.
News is suggesting that opiods were found in Prince's safe - and the next logical shoe fall will be that Prince died to a Percocet overdose. With the debt being so sky high, that's all ENDO needs to sink it further into the toilet at this point given the aleady weak painkiller sales across the board due to all the opiod related fears.
Agree. Not sure what is causing this? is it the VRX effect? is that why this is being taken to the woodshed? Its a low volume manipulation though for the last 3 days.
Sentiment: Strong Buy
Tonight, in the coattails of the Valeant testimony on Capital Hill and it's subsequent after hours relief rally, local media stations are reporting that DEA agents have been recruited to aid in the investigation, speculating that prescription pain killers may have been the cause of his death. Interesting headline, considering the autopsy results have yet to be released. Look's like this one may not be joining in on the party tomorrow. Accumulate on weakness. Capitalism is legal... And so is slander... apparently.
I am an outsider buying each time they bring it down to these levels. 1620 shares and counting. Just keep it coming...